This is the authors' abstract. We don't add key points for this paper.
Serologic and biologic properties of an example of anti-Co b were investigated. The antibody was of the IgG class, and it bound small amounts of complement. It reacted optimally in the albumin-antiglobulin test with little or no enhancement of its reactivity in tests using enzymes. Additional experiments indicated that the Co b antigen is resistant to treatment with chemicals known to destroy other antigens. The antibody caused shortened survival of radiolabeled Co(b+) donor red cells in our patient. At 24 hours, nearly 50 percent of the red cells were no longer detectable in the circulation. It is concluded that anti-Co b is a clinically relevant antibody, a fact that must be taken into account when transfusing patients with anti-Co b Immunohematology 1996; 12:11-13.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Hoffmann et al. (1996) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: